Liquid Thromboplastin Reagent Stability via Segmentation and Chelation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current liquid thromboplastin reagents have limited stability and shelf life, and freeze-dried versions require significant preparation time, introducing variability in prothrombin time measurements.

Innovation Solution

A two-part kit with separate containers for thromboplastin tissue factor and calcium, where a chelator is included in the tissue factor component to extend shelf life by protecting against divalent metal ion-dependent deterioration, allowing for immediate mixing and use, thereby reducing preparation time and increasing stability to at least 2-5 years.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If liquid thromboplastin reagent is prepared in a single vial with all components, then convenience of use is improved, but shelf life is limited to no greater than 1 year

Engineering Contradiction:
Improveconvenience of useVSAvoidshelf life
Core Design Contradiction:
Ease of operationVSDuration of action of stationary object

Solution Approach 1:

The reagent system is divided into separate components: a lyophilized thromboplastin powder in a first container and a liquid solvent containing calcium ions in a second container. This segmentation allows each component to be optimized independently - the thromboplastin remains stable in lyophilized form while the calcium solution is prepared separately, extending overall shelf life beyond 1 year while maintaining ease of use through simple mixing at the time of use.

Inventive Principle:
Principle #1Segmentation

2Duration of action of stationary object

If freeze-dried thromboplastin is used, then shelf life is extended, but preparation time is significantly increased and measurement precision is reduced

Engineering Contradiction:
Improveshelf lifeVSAvoidpreparation time
Core Design Contradiction:
Duration of action of stationary objectVSLoss of time

Solution Approach 1:

The calcium ions are pre-prepared in a stable liquid solvent solution that can be stored separately for extended periods. This preliminary preparation eliminates the need for time-consuming reconstitution procedures associated with traditional freeze-dried thromboplastin, as the calcium solution is ready to use immediately upon mixing with the lyophilized thromboplastin powder, reducing preparation time while maintaining extended shelf life.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If calcium ions are included in the thromboplastin solution, then coagulation function is enabled, but divalent metal ion-dependent deterioration occurs

Engineering Contradiction:
Improvecoagulation functionVSAvoidcompositional stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The system segments calcium ions into a separate liquid solvent component rather than including them directly with the thromboplastin powder. This separation prevents divalent metal ion-dependent deterioration of the thromboplastin while maintaining coagulation function, as calcium ions are introduced only when needed at the time of use through simple mixing of the two components.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution significantly extends the shelf life of liquid thromboplastin reagents, reduces preparation time, and minimizes variability in prothrombin time measurements by preventing divalent metal ion-dependent instability, ensuring consistent performance over extended storage periods.

Implementation Method 1

a chelator is included in the tissue factor component to extend shelf life by protecting against divalent metal ion-dependent deterioration

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

The prothrombin time (PT) is used with patient plasmas to determine either naturally occurring deficiencies in the extrinsic pathway of blood coagulation

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentEP3414576B1A two component "mix and use" liquid thromboplastin reagent, methods of making, and methods of use thereof
Publication Date: 2024.04.03 INSTRUMENTATION LABORATORY COMPANY
  • EP3414576B1 patent drawingFigure 1A
  • EP3414576B1 patent drawingFigure 1B
  • EP3414576B1 patent drawingFigure 1C

AI summary

What is described is a kit for preparing a liquid thromboplastin reagent for a prothrombin time assay. The kit simplifies and minimizes reagent preparation time and is stable for 2-5 years.